Incannex Healthcare (IXHL) Shares Outstanding (Diluted Average) (2022 - 2026)
Incannex Healthcare's (IXHL) quarterly Shares Outstanding (Diluted Average) came in at $12.3 million in Q1 2026, up 1931.12% year-on-year from $607962.0 in Q1 2025, and down 96.47% quarter-over-quarter from $349.5 million in Q4 2025.
Incannex Healthcare (IXHL) Shares Outstanding (Diluted Average) (2022 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Shares Outstanding (Diluted Average) across 5 years of filings, most recently posting $12.3 million for Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $12.3 million, up 1931.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.3 million (up 1931.12% YoY), and the FY2025 annual result was $34.5 million, up 113.15% from the prior year.
- Shares Outstanding (Diluted Average) came in at $12.3 million for Q1 2026 at Incannex Healthcare, down from $349.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $349.5 million in Q4 2025 to a low of $607962.0 in Q1 2025.
- The 5-year median for Shares Outstanding (Diluted Average) is $15.9 million (2023), against an average of $60.9 million.
- Across the five-year window, Shares Outstanding (Diluted Average) tumbled 96.17% in 2025 and surged 1931.12% in 2026, its largest moves.
- Incannex Healthcare's Shares Outstanding (Diluted Average) stood at $14.9 million in 2022, then advanced by 6.52% to $15.9 million in 2023, then climbed by 10.65% to $17.6 million in 2024, then soared by 1889.75% to $349.5 million in 2025, then slumped by 96.47% to $12.3 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $12.3 million (Q1 2026), $349.5 million (Q4 2025), and $310.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | 12.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.35 Mn |
| Dec 31, 2025 | 349.46 Mn |
| Sep 30, 2025 | 310.31 Mn |
| Jun 30, 2025 | 34.45 Mn |
| Mar 31, 2025 | 607,962.00 |
| Dec 31, 2024 | 17.56 Mn |
| Sep 30, 2024 | 17.64 Mn |
| Jun 30, 2024 | 16.16 Mn |
| Mar 31, 2024 | 15.87 Mn |
| Dec 31, 2023 | 15.87 Mn |
| Sep 30, 2023 | 15.87 Mn |
| Jun 30, 2023 | 15.38 Mn |
| Mar 31, 2023 | 15.87 Mn |
| Dec 31, 2022 | 14.90 Mn |